PATENT CLAIM ANALYSIS

Application Number: 15758709
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["544", "171000"]

Abstract:
Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.

Claim (Index 37):
The compound of  claim 34 , or a pharmaceutically acceptable salt or solvate thereof, wherein:\n ring C is a monocyclic C 2 -C 8 heterocycloalkyl containing at least 1 N atom in the ring that is selected from aziridinyl, azetidinyl, pyrrolidinyl, morpholinyl, thiomorpholinyl, piperidinyl, piperazinyl, or azepanyl.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 90.0
- Lexical Diversity: 1.54839
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15758712', '15695911', '15023465', '13388502', '13821190']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7767785663639636
- 35 USC 102 Novelty (BERT): 0.5770169001245872
- Combined Prediction Score: 0.7568023997400259
- Mean Citation Score: 361.407644
- Max Citation Score: 488.3862
- Similarity Product: 380.6839470874072

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test